Literature DB >> 22886406

O blood group and the risk of major bleeding: a single-center survey.

Massimo Franchini, Silvia Crestani, Chiara Rossi, Francesco Frattini, Carlo Mengoli, Ivano Giacomini, Mario Luppi, Carlo Bonfanti.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 22886406     DOI： 10.1007/s11239-012-0783-x

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN： 0929-5305            Impact factor:   2.300


× No keyword cloud information.
  12 in total

1.  THE PLASMA CONCENTRATION OF FACTOR VIII IN THE NORMAL POPULATION. II. THE EFFECTS OF AGE, SEX AND BLOOD GROUP.

Authors:  A E PRESTON; A BARR
Journal:  Br J Haematol       Date:  1964-04       Impact factor: 6.998

2.  Relationship between ABO blood group and bleeding complications in orally anticoagulated patients.

Authors:  M Franchini; S Crestani; F Frattini; C Mengoli; C Bonfanti
Journal:  J Thromb Haemost       Date:  2012-08       Impact factor: 5.824

3.  The relationship between ABO blood group and the risk of bleeding during vitamin K antagonist treatment.

Authors:  A A Garcia; J F van der Heijden; J C M Meijers; F R Rosendaal; P H Reitsma
Journal:  J Thromb Haemost       Date:  2006-06       Impact factor: 5.824

Review 4.  The relationship between ABO histo-blood group, factor VIII and von Willebrand factor.

Authors:  J O'Donnell; M A Laffan
Journal:  Transfus Med       Date:  2001-08       Impact factor: 2.019

Review 5.  ABO blood group determines plasma von Willebrand factor levels: a biologic function after all?

Authors:  P Vince Jenkins; James S O'Donnell
Journal:  Transfusion       Date:  2006-10       Impact factor: 3.157

6.  Haemostatic genetic variants, ABO blood group and bleeding risk during oral anticoagulant treatment after cerebral ischaemia of arterial origin.

Authors:  D M O Pruissen; F R Rosendaal; J W Gorter; A A Garcia; L J Kappelle; A Algra
Journal:  J Neurol       Date:  2007-11-14       Impact factor: 4.849

Review 7.  Non-O blood type is the commonest genetic risk factor for VTE: results from a meta-analysis of the literature.

Authors:  Francesco Dentali; Anna Paola Sironi; Walter Ageno; Sara Turato; Carlo Bonfanti; Francesco Frattini; Silvia Crestani; Massimo Franchini
Journal:  Semin Thromb Hemost       Date:  2012-06-27       Impact factor: 4.180

8.  The effect of ABO blood group on the diagnosis of von Willebrand disease.

Authors:  J C Gill; J Endres-Brooks; P J Bauer; W J Marks; R R Montgomery
Journal:  Blood       Date:  1987-06       Impact factor: 22.113

Review 9.  ABO blood group, hypercoagulability, and cardiovascular and cancer risk.

Authors:  Massimo Franchini; Emmanuel J Favaloro; Giovanni Targher; Giuseppe Lippi
Journal:  Crit Rev Clin Lab Sci       Date:  2012-08-03       Impact factor: 6.250

10.  Relationship between ABO blood group and von Willebrand factor levels: from biology to clinical implications.

Authors:  Massimo Franchini; Franco Capra; Giovanni Targher; Martina Montagnana; Giuseppe Lippi
Journal:  Thromb J       Date:  2007-09-25
View more
  2 in total

1.  O blood group is a risk factor for severe mucosal hemorrhage in orally anticoagulated patients.

Authors:  Massimo Franchini; Chiara Rossi; Carlo Mengoli; Moreno Meschieri; Francesco Frattini; Silvia Crestani; Ivano Giacomini; Mario Luppi; Carlo Bonfanti
Journal:  J Thromb Thrombolysis       Date:  2013-10       Impact factor: 2.300

2.  The association between ABO blood group and obstetric hemorrhage.

Authors:  Lior Drukker; Naama Srebnik; Deborah Elstein; Lorinne Levitt; Arnon Samueloff; Rivka Farkash; Sorina Grisaru-Granovsky; Hen Y Sela
Journal:  J Thromb Thrombolysis       Date:  2016-10       Impact factor: 2.300
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.